MeiraGTx Holdings plc (MGTX) DCF Valuation

Valoración de DCF de Meiragtx Holdings PLC (MGTX)

US | Healthcare | Biotechnology | NASDAQ
MeiraGTx Holdings plc (MGTX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

MeiraGTx Holdings plc (MGTX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Descubra el verdadero valor de Meiragtx Holdings PLC (MGTX) con nuestra calculadora DCF avanzada! Ajuste los supuestos clave, explore varios escenarios y examine cómo los diferentes factores influyen en la valoración de Meiragtx Holdings PLC (MGTX), todo dentro de una plantilla completa de Excel.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 13.3 15.6 37.7 15.9 14.0 15.7 17.5 19.6 21.9 24.5
Revenue Growth, % 0 17.09 142.25 -57.77 -11.95 11.84 11.84 11.84 11.84 11.84
EBITDA -51.4 -53.7 -71.4 -115.9 -57.1 -15.7 -17.5 -19.6 -21.9 -24.5
EBITDA, % -386.33 -344.93 -189.38 -728.3 -407.02 -100 -100 -100 -100 -100
Depreciation 3.3 4.2 7.9 8.7 13.7 7.1 7.9 8.8 9.9 11.1
Depreciation, % 25.18 26.8 20.88 54.79 97.95 45.12 45.12 45.12 45.12 45.12
EBIT -54.7 -57.9 -79.3 -124.7 -70.8 -15.7 -17.5 -19.6 -21.9 -24.5
EBIT, % -411.51 -371.73 -210.27 -783.1 -504.97 -100 -100 -100 -100 -100
Total Cash 227.2 209.5 137.7 115.5 129.6 15.7 17.5 19.6 21.9 24.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 23.3 38.5 35.0 29.0 23.4
Account Receivables, % 175.58 247.25 92.88 182.31 167.05
Inventories 4.5 7.1 8.1 8.1 .0 4.8 5.3 5.9 6.7 7.4
Inventories, % 33.58 45.5 21.49 51.09 0 30.33 30.33 30.33 30.33 30.33
Accounts Payable 3.8 7.1 15.3 16.6 16.0 9.9 11.0 12.3 13.8 15.4
Accounts Payable, % 28.28 45.84 40.71 104.37 114.45 62.97 62.97 62.97 62.97 62.97
Capital Expenditure -9.0 -37.0 -55.2 -45.0 -20.2 -14.7 -16.4 -18.3 -20.5 -22.9
Capital Expenditure, % -67.56 -237.87 -146.46 -282.43 -143.93 -93.51 -93.51 -93.51 -93.51 -93.51
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -52.5 -53.8 -71.7 -137.4 -70.8 -15.0 -16.8 -18.8 -21.0 -23.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -82.2 -101.1 -108.4 -166.4 -64.1 -25.6 -26.5 -29.7 -33.2 -37.1
WACC, % 11.13 11.04 10.96 11.25 11.25 11.13 11.13 11.13 11.13 11.13
PV UFCF
SUM PV UFCF -109.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -38
Terminal Value -415
Present Terminal Value -245
Enterprise Value -354
Net Debt -40
Equity Value -314
Diluted Shares Outstanding, MM 56
Equity Value Per Share -5.56

What You Will Receive

  • Pre-Filled Financial Model: MeiraGTx's actual data provides accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
  • Instantaneous Calculations: Automatic updates allow you to view results in real-time as adjustments are made.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for adaptability, enabling repeated application for detailed forecasts.

Key Features

  • Customizable Financial Inputs: Adjust essential metrics such as research and development expenses, revenue projections, and operational costs.
  • Instant DCF Valuation: Automatically computes intrinsic value, net present value (NPV), and additional financial metrics.
  • High-Precision Accuracy: Leverages MeiraGTx’s actual financial data for dependable valuation results.
  • Effortless Scenario Analysis: Easily evaluate various assumptions and analyze the resulting impacts.
  • Efficiency Booster: Streamlines the valuation process, eliminating the need for intricate model construction.

How It Works

  • Download: Obtain the pre-configured Excel file containing MeiraGTx Holdings plc's (MGTX) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC to suit your analysis.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time as you make changes.
  • Test Scenarios: Develop various forecasts and instantly compare the resulting outcomes.
  • Make Decisions: Leverage the valuation findings to inform your investment strategy.

Why Choose This Calculator for MeiraGTx Holdings plc (MGTX)?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for MGTX.
  • Flexible Inputs: Modify the highlighted cells to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes MeiraGTx's intrinsic value and Net Present Value.
  • Preloaded Information: Access historical and projected data for reliable analysis.
  • High-Quality Standards: Perfect for financial analysts, investors, and business advisors focusing on MGTX.

Who Should Use This Product?

  • Biotech Students: Explore gene therapy concepts and apply them using real-world data.
  • Researchers: Integrate cutting-edge models into studies or academic projects.
  • Investors: Evaluate your investment strategies and analyze valuation metrics for MeiraGTx Holdings plc (MGTX).
  • Financial Analysts: Enhance your analysis with a customizable financial model tailored for biotech firms.
  • Healthcare Entrepreneurs: Understand the market dynamics of publicly traded biotech companies like MeiraGTx Holdings plc (MGTX).

What the Template Contains

  • Historical Data: Includes MeiraGTx's past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate MeiraGTx's intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of MeiraGTx's financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.